NCT05001412 2021-08-12Chemotherapy Combined With Camrelizumab and Apatinib in First-line Treatment of ES-SCLCGuangzhou Institute of Respiratory DiseasePhase 1 Unknown36 enrolled
NCT00017251 2013-01-24Combination Chemotherapy Plus Oblimersen in Treating Patients With Previously Untreated Extensive-Stage Small Cell Lung CancerNational Cancer Institute (NCI)Phase 1 Completed12 enrolled